VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BRO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BROBrown & Brown, Inc.
$69.27$23.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBROQuarterly Financials

Brown & Brown, Inc. (BRO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Brown & Brown, Inc. (BRO) quarterly income statement — complete revenue, gross profit & net income history

BRO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue1.9B1.67B1.61B1.25B1.39B1.09B1.19B1.15B1.24B972.4M1.07B1.04B1.11B893.2M926.4M839.1M904.3M737.91M770.1M726.1M
Revenue Growth %37.26%53.26%35.41%8.23%11.96%11.99%11.26%11.39%11.64%8.87%15.07%23.47%22.53%21.04%20.3%15.56%11.05%15.29%14.7%21.39%
Medical Costs & Claims907M270M793M640M683M583M607M585M631M553.7M532M530M571M475.6M470.3M412.1M459M416.8M395M395.6M
Medical Cost Ratio %47.71%16.18%49.38%51.24%49.31%53.54%51.18%50.69%51.01%56.94%49.91%51.16%51.53%53.25%50.77%49.11%50.76%56.48%51.29%54.48%
Gross Profit994M1.4B813M609M702M506M579M569M606M418.7M534M506M537M417.6M456.1M427M445.3M321.11M375.1M330.5M
Gross Margin %52.29%83.82%50.62%48.76%50.69%46.46%48.82%49.31%48.99%43.06%50.09%48.84%48.47%46.75%49.23%50.89%49.24%43.52%48.71%45.52%
Gross Profit Growth %41.6%176.48%40.41%7.03%15.84%20.85%8.43%12.45%12.85%0.26%17.08%18.5%20.59%30.05%21.59%29.2%15.72%22.29%21.54%31.34%
Operating Expenses461M970M391M272M250M269M221M228M215M211.5M219M213M212M195.5M224.4M196.5M166M150.13M139.8M134.6M
OpEx / Revenue %24.25%58.12%24.35%21.78%18.05%24.7%18.63%19.76%17.38%21.75%20.54%20.56%19.13%21.89%24.22%23.42%18.36%20.35%18.15%18.54%
Depreciation & Amortization123M135M107M62M64M58M57M55M54M51.8M51M52M51M49.3M54.8M42.6M39.2M38.88M38.7M38.3M
Combined Ratio %71.96%74.3%73.72%73.02%67.36%78.24%69.81%70.45%68.39%78.69%70.45%71.72%70.67%75.13%74.99%72.53%69.11%76.83%69.45%73.02%
Operating Income533M429M422M337M452M237M358M341M391M207.2M315M293M325M222.1M231.7M230.5M279.3M170.97M235.3M195.9M
Operating Margin %28.04%25.7%26.28%26.98%32.64%21.76%30.19%29.55%31.61%21.31%29.55%28.28%29.33%24.87%25.01%27.47%30.89%23.17%30.55%26.98%
Operating Income Growth %17.92%81.01%17.88%-1.17%15.6%14.38%13.65%16.38%20.31%-6.71%35.95%27.12%16.36%29.9%-1.53%17.66%10.22%26.7%28.21%36.84%
EBITDA656M564M529M399M516M295M415M396M445M259M366M345M376M271.4M286.5M273.1M318.5M209.86M274M234.2M
EBITDA Margin %34.51%33.79%32.94%31.95%37.26%27.09%34.99%34.32%35.97%26.64%34.33%33.3%33.94%30.39%30.93%32.55%35.22%28.44%35.58%32.25%
Interest Expense0100M100M53M48M54M50M52M50M49.7M48M50M49M47.4M43.4M37.7M19.7M22.41M17.5M18M
Non-Operating Income08M0-27M-23M-92M-9M-57M-23M-197.6M25M-11M-18M-19.6M-29.7M-6M-5.4M7.74M21.3M-8.4M
Pretax Income533M321M311M311M427M275M317M346M364M355.1M242M254M294M194.3M218M198.8M265M140.82M196.5M186.3M
Pretax Margin %28.04%19.23%19.36%24.9%30.83%25.25%26.73%29.98%29.43%36.52%22.7%24.52%26.53%21.75%23.53%23.69%29.3%19.08%25.52%25.66%
Income Tax107M53M82M77M93M64M78M87M71M86.5M66M64M58.7M49.1M56.9M53.6M44.7M39.1M50.1M47M
Effective Tax Rate %20.08%16.51%26.37%24.76%21.78%23.27%24.61%25.14%19.51%24.36%27.27%25.2%19.97%25.27%26.1%26.96%16.87%27.77%25.5%25.23%
Net Income426M264M227M231M331M210M234M257M293M268.7M176M190M236M145.2M161.1M142.5M215.9M101.72M146.35M139.29M
Net Margin %22.41%15.82%14.13%18.49%23.9%19.28%19.73%22.27%23.69%27.63%16.51%18.34%21.3%16.26%17.39%16.98%23.87%13.78%19%19.18%
Net Income Growth %28.7%25.71%-2.99%-10.12%12.97%-21.85%32.95%35.26%24.15%85.06%9.25%33.33%9.31%42.75%10.08%2.3%8.09%4.52%9.24%43.92%
EPS (Diluted)1.260.590.680.781.150.730.820.901.020.940.620.670.830.510.570.510.780.360.520.49
EPS Growth %9.57%-19.18%-17.07%-13.33%12.75%-22.34%32.26%34.33%22.89%84.31%8.77%31.37%6.41%41.67%9.62%4.08%11.43%5.88%10.64%44.12%
EPS (Basic)1.280.790.690.791.160.750.820.901.030.940.620.670.830.510.570.510.780.360.520.49
Diluted Shares Outstanding339M339M332M293M285M284M283M283M283M281.9M281.3M280.4M279.4M279.02M278.7M278.2M278.57M278.13M277.55M276.88M